28 March 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the ...
18 January 2024 - NICE has published additional draft guidance on the use of remdesivir and the combination of tixagevimab ...
11 January 2024 - A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be ...
29 November 2023 - NICE has published final evidence-based recommendations on the use of foslevodopa with foscarbidopa (Produodopa) for the ...
3 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
31 May 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
4 May 2023 - NICE is conducting a partial rapid review of TA878. ...
14 December 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use of ...
2 November 2022 - NICE is unable to make a recommendation on slow-release potassium bicarbonate–potassium citrate (Sibnayal) for treating distal renal ...
19 October 2022 - NICE has published evidence based recommendations on the use of oestradiol hemifumarate with norethisterone acetate and ...
13 May 2022 - Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended ...
27 January 2021 - NICE has completed its review of trifluridine with tipiracil hydrochloride for the treatment of patients with ...
15 March 2020 - PrEP will be routinely available across England as part of the government’s aim to end HIV transmission ...
26 February 2020 - NICE is currently in the process of evaluating Vertex Pharmaceuticals’ triple combination therapy — known as ...
17 September 2019 - Patients have formed a buyers' club to source a version of Orkambi after the drug's manufacturer and ...